股本结构
单位:万股
公告日期 | 2024-03-05 | 2024-03-05 | 2023-11-09 | 2023-11-09 | 2023-08-08 | 2023-05-09 |
---|---|---|---|---|---|---|
证券总股本 | 22558.23 | 22540.93 | 22540.93 | 22540.93 | 22532.21 | 9544.41 |
普通股本 | 22558.23 | 22540.93 | 22540.93 | 22540.93 | 22532.21 | 9544.41 |
优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
变动日期 | 2024-02-27 | 2023-12-31 | 2023-11-03 | 2023-09-30 | 2023-08-03 | 2023-03-31 |
注释:中概股证券总股本=普通股股本/
存托凭证比例
历史变动
公告日期 | 变动后普通股本(万股) | 变动后优先股(万股) | 变动原因 | 变动日期 |
---|---|---|---|---|
2024-03-05 | 22558.23 | 未披露 | 定期报告 | 2024-02-27 |
2024-03-05 | 22540.93 | 未披露 |
更多>>
From December 31,2022 to December 31,2023
Issuance of common stock and warrants in connection with a private offering, net of offering costs of $10,779
Vesting of restricted stock
Issuance of common stock pursuant to Employee Stock Purchase Plan
Issuance of common stock for restricted stock units vested
|
2023-12-31 |
2023-11-09 | 22540.93 | 未披露 | 定期报告 | 2023-11-03 |
2023-11-09 | 22540.93 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Issuance of common stock and accompanying warrants in connection with a private offering, net of offering costs of $10,779
Issuance of common stock pursuant to Employee Stock Purchase Plan
|
2023-09-30 |
2023-08-08 | 22532.21 | 未披露 | 定期报告 | 2023-08-03 |
2023-04-28 | 9544.41 | 未披露 | 定期报告 | 2023-04-18 |
2023-05-09 | 9544.41 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Issuance of common stock pursuant to Employee Stock Purchase Plan
Issuance of common stock for restricted stock units vested
Vesting of restricted stock
|
2023-03-31 |
2023-03-17 | 9498.46 | 未披露 | 定期报告 | 2023-03-10 |
2023-03-17 | 9442.32 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Issuance of common stock in connection with a private offering, net of offering costs of $184
Issuance of common stock for restricted stock units vested
Issuance of common stock pursuant to Employee Stock Purchase Plan
Vesting of restricted stock
Exercise of stock options
|
2022-12-31 |
2022-11-03 | 9447.68 | 未披露 | 定期报告 | 2022-10-31 |
2022-11-03 | 9391.42 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Vesting of restricted stock
Exercise of stock options
Issuance of common stock pursuant to Employee Stock Purchase Plan
Issuance of common stock in connection with a private offering, net of offering costs of $184
Issuance of common stock for restricted stock units vested
|
2022-09-30 |
2022-08-09 | 9395.40 | 未披露 | 定期报告 | 2022-08-05 |
2022-08-09 | 7673.62 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Vesting of restricted stock
Exercise of stock options
Issuance of common stock for restricted stock units vested
|
2022-06-30 |
2022-05-10 | 7711.67 | 未披露 | 定期报告 | 2022-05-05 |
2022-04-27 | 7711.15 | 未披露 | 定期报告 | 2022-04-19 |
2022-05-10 | 7655.39 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Vesting of restricted stock
Exercise of stock options
Issuance of common stock pursuant to Employee Stock Purchase Plan
Issuance of common stock for restricted stock units vested
|
2022-03-31 |
2022-03-03 | 7647.71 | 未披露 | 定期报告 | 2022-02-25 |
2022-03-03 | 7575.27 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Vesting of restricted stock
Exercise of stock options
Issuance of common stock pursuant to Employee Stock Purchase Plan
Issuance of common stock for restricted stock units vested
|
2021-12-31 |
2021-11-08 | 7646.35 | 未披露 | 定期报告 | 2021-11-04 |
2021-11-08 | 7530.01 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Vesting of restricted stock
Exercise of stock options
Issuance of common stock pursuant to Employee Stock Purchase Plan
|
2021-09-30 |
2021-08-09 | 7599.35 | 未披露 | 定期报告 | 2021-08-05 |
2021-08-09 | 7483.50 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Vesting of restricted stock
Exercise of stock options
Issuance of common stock for restricted stock units vested
|
2021-06-30 |
2021-04-27 | 7590.97 | 未披露 | 定期报告 | 2021-04-19 |
2021-05-06 | 7449.32 | 未披露 |
更多>>
From December 31, 2020 To March 31, 2021
Vesting of restricted stock
Exercise of stock options
Issuance of common stock pursuant to Employee Stock Purchase Plan
Issuance of common stock for restricted stock units vested
|
2021-03-31 |
2021-02-26 | 7552.77 | 未披露 | 定期报告 | 2021-02-19 |
2021-02-26 | 7387.49 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Issuance of common stock in connection with a public offering, net of underwriting discounts, commissions, and offering costs
Vesting of restricted stock
Exercise of stock options
Issuance of common stock pursuant to Employee Stock Purchase Plan
|
2020-12-31 |
2020-11-10 | 7592.79 | 未披露 | 定期报告 | 2020-11-05 |
2020-11-10 | 7247.59 | 未披露 |
更多>>
From June 30,2020 to September 30,2020
Vesting of restricted stock
Exercise of stock options
Issuance of common stock pursuant to Employee Stock Purchase Plan
|
2020-09-30 |
2020-08-11 | 7582.81 | 未披露 | 定期报告 | 2020-08-06 |
2020-08-11 | 7197.26 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Issuance of common stock in connection with public offering,net of underwriting discounts,commissions,and offering costs
Vesting of restricted stock
Exercise of stock options
|
2020-06-30 |
2020-05-21 | 7577.22 | 未披露 |
更多>>
On May 21, 2020, Gossamer Bio, Inc. (the “Company”) completed the public offering of 9,433,963 shares (the “Shares”) of common stock, par value $0.0001 per share, of the Company (the “Common Stock”) at a public offering price of $13.25 per share (the “Common Stock Offering”).
|
2020-05-21 |
2020-05-12 | 6635.84 | 未披露 | 定期报告 | 2020-05-07 |
2020-04-27 | 6634.79 | 未披露 | 定期报告 | 2020-04-22 |
2020-05-12 | 6209.43 | 未披露 |
更多>>
From December 31, 2019 to March 31, 2020
Vesting of restricted stock
Exercise of stock options
Issuance of common stock pursuant to Employee Stock Purchase Plan
|
2020-03-31 |
2020-03-24 | 6633.66 | 未披露 | 定期报告 | 2020-03-18 |
2020-03-24 | 6163.55 | 未披露 |
更多>>
from December 31, 2018 to December 31, 2019
Issuance of common stock in connection with a public offering,net of underwriting discounts,commissions,and offering costs
Conversion of convertible preferred stock into common stock
Vesting of restricted stock
Exercise of stock options
|
2019-12-31 |
2019-11-12 | 6603.81 | 未披露 | 定期报告 | 2019-11-06 |
2019-11-12 | 6098.50 | 未披露 |
更多>>
from June 30, 2019 to September 30, 2019
Vesting of restricted stock
Exercise of stock options
|
2019-09-30 |
2019-08-08 | 6592.52 | 未披露 | 定期报告 | 2019-08-05 |
2019-08-08 | 6046.74 | 未披露 |
更多>>
from March 31, 2019 to June 30,2019
Vesting of restricted stock
Exercise of stock options
|
2019-06-30 |
2019-04-30 | 6589.33 | 未披露 | 定期报告 | 2019-04-22 |
2019-05-14 | 6002.95 | 未披露 |
更多>>
from December 31, 2018 to March 31, 2019
Conversion of convertible preferred stock into common stock
Issuance of common stock in connection with a public offering, net of underwriting discounts, commissions, and offering costs
Vesting of restricted stock
Stock-based compensation
|
2019-03-31 |
2019-03-22 | 6587.55 | 未披露 |
更多>>
In January 2019, the Company’s board of directors and stockholders approved and adopted the 2019 Incentive Award Plan (the “2019 Plan”). The 2019 Plan became effective on February 6, 2019, the day prior to the effectiveness of the registration statement filed in connection with the IPO. Under the 2019 Plan, the Company may grant stock options, stock appreciation rights, restricted stock, restricted stock units, and other stock or cash-based awards to individuals who are then employees, officers, directors or consultants of the Company, and employees and consultants of the Company’s subsidiaries. A total of 5,750,000 shares of common stock were approved to be initially reserved for issuance under the 2019 Plan. The number of shares that remain available for issuance under the 2017 Plan as of the effective date of the 2019 Plan and shares subject to outstanding awards under the 2017 Plan as of the effective date of the 2019 Plan that are subsequently canceled, forfeited or repurchased by the Company will be added to the shares reserved under the 2019 Plan.
|
2019-03-18 |
2019-02-08 | 6327.69 | 未披露 |
更多>>
1.Common stock offered 17,250,000 shares
2.The number of shares of our common stock to be outstanding after this offering set forth above is based on 46,026,910 shares of our common stock outstanding as of September 30, 2018
3. A 20,612-for-one stock split of our common stock effected in January 2018
4. A one-for-4.5 reverse stock split of our common stock, which we effected on January 23, 2019
|
2019-02-08 |
2019-03-22 | 805.14 | 13722.08 |
更多>>
from December 31, 2017 to December 31, 2018
Issuance of Series A preferred stock for cash, net of $0.4 million in offering costs
Issuance of stock for acquisition
Issuance of Series A preferred stock to convert debt and accrued interest
Issuance of Series B preferred stock for cash, net of $0.5 million in offering costs
Vesting of restricted stock
Incremental vesting conditions place on previously issued common shares
|
2018-12-31 |
2019-01-30 | 773.38 | 未披露 | 定期报告 | 2018-09-30 |
From December 31,2022 to December 31,2023
Issuance of common stock and warrants in connection with a private offering, net of offering costs of $10,779
Vesting of restricted stock
Issuance of common stock pursuant to Employee Stock Purchase Plan
Issuance of common stock for restricted stock units vested
From June 30, 2023 to September 30, 2023
Issuance of common stock and accompanying warrants in connection with a private offering, net of offering costs of $10,779
Issuance of common stock pursuant to Employee Stock Purchase Plan
From December 31, 2022 to March 31, 2023
Issuance of common stock pursuant to Employee Stock Purchase Plan
Issuance of common stock for restricted stock units vested
Vesting of restricted stock
From December 31, 2021 to December 31, 2022
Issuance of common stock in connection with a private offering, net of offering costs of $184
Issuance of common stock for restricted stock units vested
Issuance of common stock pursuant to Employee Stock Purchase Plan
Vesting of restricted stock
Exercise of stock options
From June 30, 2022 to September 30, 2022
Vesting of restricted stock
Exercise of stock options
Issuance of common stock pursuant to Employee Stock Purchase Plan
Issuance of common stock in connection with a private offering, net of offering costs of $184
Issuance of common stock for restricted stock units vested
From March 31, 2022 to June 30, 2022
Vesting of restricted stock
Exercise of stock options
Issuance of common stock for restricted stock units vested
From December 31, 2021 to March 31, 2022
Vesting of restricted stock
Exercise of stock options
Issuance of common stock pursuant to Employee Stock Purchase Plan
Issuance of common stock for restricted stock units vested
From December 31, 2020 to December 31, 2021
Vesting of restricted stock
Exercise of stock options
Issuance of common stock pursuant to Employee Stock Purchase Plan
Issuance of common stock for restricted stock units vested
From June 30, 2021 to September 30, 2021
Vesting of restricted stock
Exercise of stock options
Issuance of common stock pursuant to Employee Stock Purchase Plan
From March 31, 2021 to June 30, 2021
Vesting of restricted stock
Exercise of stock options
Issuance of common stock for restricted stock units vested
From December 31, 2020 To March 31, 2021
Vesting of restricted stock
Exercise of stock options
Issuance of common stock pursuant to Employee Stock Purchase Plan
Issuance of common stock for restricted stock units vested
From December 31, 2019 to December 31, 2020
Issuance of common stock in connection with a public offering, net of underwriting discounts, commissions, and offering costs
Vesting of restricted stock
Exercise of stock options
Issuance of common stock pursuant to Employee Stock Purchase Plan
From June 30,2020 to September 30,2020
Vesting of restricted stock
Exercise of stock options
Issuance of common stock pursuant to Employee Stock Purchase Plan
From March 31, 2020 to June 30, 2020
Issuance of common stock in connection with public offering,net of underwriting discounts,commissions,and offering costs
Vesting of restricted stock
Exercise of stock options
On May 21, 2020, Gossamer Bio, Inc. (the “Company”) completed the public offering of 9,433,963 shares (the “Shares”) of common stock, par value $0.0001 per share, of the Company (the “Common Stock”) at a public offering price of $13.25 per share (the “Common Stock Offering”).
From December 31, 2019 to March 31, 2020
Vesting of restricted stock
Exercise of stock options
Issuance of common stock pursuant to Employee Stock Purchase Plan
from December 31, 2018 to December 31, 2019
Issuance of common stock in connection with a public offering,net of underwriting discounts,commissions,and offering costs
Conversion of convertible preferred stock into common stock
Vesting of restricted stock
Exercise of stock options
from June 30, 2019 to September 30, 2019
Vesting of restricted stock
Exercise of stock options
from March 31, 2019 to June 30,2019
Vesting of restricted stock
Exercise of stock options
from December 31, 2018 to March 31, 2019
Conversion of convertible preferred stock into common stock
Issuance of common stock in connection with a public offering, net of underwriting discounts, commissions, and offering costs
Vesting of restricted stock
Stock-based compensation
In January 2019, the Company’s board of directors and stockholders approved and adopted the 2019 Incentive Award Plan (the “2019 Plan”). The 2019 Plan became effective on February 6, 2019, the day prior to the effectiveness of the registration statement filed in connection with the IPO. Under the 2019 Plan, the Company may grant stock options, stock appreciation rights, restricted stock, restricted stock units, and other stock or cash-based awards to individuals who are then employees, officers, directors or consultants of the Company, and employees and consultants of the Company’s subsidiaries. A total of 5,750,000 shares of common stock were approved to be initially reserved for issuance under the 2019 Plan. The number of shares that remain available for issuance under the 2017 Plan as of the effective date of the 2019 Plan and shares subject to outstanding awards under the 2017 Plan as of the effective date of the 2019 Plan that are subsequently canceled, forfeited or repurchased by the Company will be added to the shares reserved under the 2019 Plan.
1.Common stock offered 17,250,000 shares
2.The number of shares of our common stock to be outstanding after this offering set forth above is based on 46,026,910 shares of our common stock outstanding as of September 30, 2018
3. A 20,612-for-one stock split of our common stock effected in January 2018
4. A one-for-4.5 reverse stock split of our common stock, which we effected on January 23, 2019
from December 31, 2017 to December 31, 2018
Issuance of Series A preferred stock for cash, net of $0.4 million in offering costs
Issuance of stock for acquisition
Issuance of Series A preferred stock to convert debt and accrued interest
Issuance of Series B preferred stock for cash, net of $0.5 million in offering costs
Vesting of restricted stock
Incremental vesting conditions place on previously issued common shares